MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,675K
Net Income
-$71K
Net Profit Margin
-2.65%
EPS
-$0.01
Unit: Thousand (K) dollars
Revenue Breakdown
US
Non Us
Anti Aging Market
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product sales
2,675
2,315
2,155
2,369
Cost of sales
1,217
954
1,066
1,048
General and administrative
1,062
1,122
946
789
Selling and marketing
276
273
279
280
Research and development
155
156
177
158
Total operating expenses
2,710
2,505
2,468
2,275
Income (loss) from operations
-35
-190
-313
94
Interest expense
1
2
0
1
Interest expense - related party
33
33
35
36
Other (expense) income
-2
5
-
-
Total other expense, net
-36
-30
-35
-37
Net income (loss)
-71
-220
-348
57
Undistributed earnings allocated to participating securities
-
-
-
28
Net income (loss) attributable to common stockholders
-71
-
-
29
Basic EPS
-0.01
-0.03
-0.032
0
Diluted EPS
-0.01
-0.03
-0.033
0
Basic Average Shares
8,004,389
8,004,389
8,004,389
8,004,389
Diluted Average Shares
8,004,389
8,004,389
7,841,481
8,167,297
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (loss)
attributable to common...
-$71K
(-205.97%↓ Y/Y)
US
$2,224K
Non Us
$300K
Net income (loss)
-$71K
(-155.04%↓ Y/Y)
Biomedical Market
$2,524K
(9.60%↑ Y/Y)
Anti Aging Market
$151K
(4.86%↑ Y/Y)
Total other expense,
net
-$36K
(5.26%↑ Y/Y)
Income (loss) from
operations
-$35K
(-120.96%↓ Y/Y)
Product sales
$2,675K
(9.32%↑ Y/Y)
Interest expense -
related party
$33K
(-8.33%↓ Y/Y)
Other (expense)
income
-$2K
Interest expense
$1K
(-50.00%↓ Y/Y)
Total operating
expenses
$2,710K
(18.86%↑ Y/Y)
Cost of sales
$1,217K
(31.28%↑ Y/Y)
General and
administrative
$1,062K
(17.35%↑ Y/Y)
Selling and marketing
$276K
(-3.50%↓ Y/Y)
Research and development
$155K
(-4.32%↓ Y/Y)
Buy us a coffee
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)